CCM
ENFN

CAAS Capital Management’s Enfusion, Inc. ENFN Stock Holding History

CAAS Capital Management’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-100,000
Closed -$2.09M – 982
2021
Q4 		$2.09M Buy
+100,000
New +$2.02M 0.05% 312

Other funds holding ENFN

FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
DIG
Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ACM
Ararat Capital Management Westport, Connecticut $178M AUM 26.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

CAAS Capital Management's ENFN Position: Q1 2022 in Review

CAAS Capital Management sold out of Enfusion, Inc. (ENFN) in Q1 2022, closing a stake of 100,000 shares — an estimated $2.09M sold.

CAAS Capital Management first reported a position in ENFN in Q4 2021 and held it in 1 quarter. The position peaked at $2.09M in Q4 2021. 64 funds tracked by Wall St. Rank hold ENFN as of Q1 2022.

  • CAAS Capital Management reported no remaining Enfusion, Inc. position as of Q1 2022 after selling out during the quarter.
  • CAAS Capital Management sold 100,000 Enfusion, Inc. shares in Q1 2022, an estimated $2.09M.
  • CAAS Capital Management first reported a position in Enfusion, Inc. in Q4 2021 and held it in 1 quarter.
  • CAAS Capital Management's Enfusion, Inc. position peaked at $2.09M in Q4 2021.
  • 64 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q1 2022.

Based on CAAS Capital Management's 13F filing for Q1 2022, filed 13 May 2022.